コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 antly potentiated by substrate inhibition of adenosine kinase.
2 nterplay between nucleoside transporters and adenosine kinase.
3 ansporter and is a substrate of T. b. brucei adenosine kinase.
4 intractable epilepsy demonstrated increased adenosine kinase.
5 excellent subversive substrate of T. gondii adenosine kinase.
6 f BTI as subversive substrates for T. gondii adenosine kinase.
9 itiation of toxicity in sympathetic neurons, adenosine kinase activity was compared in sensory and sy
10 Furthermore, both adenosine deaminase and adenosine kinase activity was significantly diminished (
12 e levels with a combination of inhibitors of adenosine kinase, adenosine deaminase, and the equilibra
13 suppress local silencing by interacting with adenosine kinase (ADK) and can suppress basal defense by
17 M #614300) that is based on mutations in the adenosine kinase (Adk) gene has been discovered recently
18 ilencing by a mechanism that correlates with adenosine kinase (ADK) inhibition, while AL2 in addition
21 ntracellular adenosine and its key regulator adenosine kinase (ADK) play important roles in vascular
22 ich involves interacting with and inhibiting adenosine kinase (ADK), a cellular enzyme associated wit
23 viral proteins interact with and inactivate adenosine kinase (ADK), a cellular enzyme important for
25 viral proteins interact with and inactivate adenosine kinase (ADK), a nucleoside kinase that catalyz
26 of adenosine by pharmacologic inhibition of adenosine kinase (ADK), the key enzyme of adenosine clea
28 s shown to decrease expression of the enzyme adenosine kinase (Adk), which is responsible for clearin
30 bercidin" analogues are potent inhibitors of adenosine kinase (AK) and are orally active in animal mo
31 -702 is a novel and selective non-nucleoside adenosine kinase (AK) inhibitor that produces increases
32 rted that analogues of tubercidin are potent adenosine kinase (AK) inhibitors with antiseizure activi
37 resistant clones exhibited disruption of the adenosine kinase (AK) locus, others displayed normal AK
38 denine phosphoribosyltransferase (APRT), and adenosine kinase (AK) to purine salvage in Leishmania do
39 ne (ADO) can be raised through inhibition of adenosine kinase (AK), a primary metabolic enzyme for AD
40 the activities of adenosine deaminase (ADA), adenosine kinase (AK), and inosine monophosphate-specifi
41 DO can be enhanced consists of inhibition of adenosine kinase (AK), the primary metabolic enzyme for
44 ll fold is similar to that of ribokinase and adenosine kinase, although sequence similarity is not im
45 virin, and both compounds are substrates for adenosine kinase, an enzyme critical for conversion to t
51 e substrates of T. gondii,but not the human, adenosine kinase are preferentially metabolized to their
52 he (redundant) purine salvage pathway enzyme adenosine kinase are susceptible to the drug, with an IC
53 orylation of one or more proteins other than adenosine kinase as a consequence of NMDA receptor activ
62 nosine accumulates high levels of dATP in an adenosine kinase-dependent process and dies within a few
67 ects of iodotubercidin (ITU, an inhibitor of adenosine kinase), erythro-9-(2-hydroxy-3-nonyl)adenine
68 ad to endothelial inflammation by increasing adenosine kinase expression, and that its knockdown in e
69 ocked with 5-iodotubercidin, an inhibitor of adenosine kinase, folate transport stimulation by AICAR
71 osine by biallelic genetic disruption of the adenosine kinase gene (Adk-/-), and respective wild-type
72 On the basis of the evidence of the role of adenosine kinase in regulating adenosine levels during h
76 ndogenous adenosine levels through selective adenosine kinase inhibition produces powerful analgesic
81 -deficient cultures were also rescued by the adenosine kinase inhibitor 5'-amino-5'-deoxyadenosine (5
86 ptive effects of AMP, when combined with the adenosine kinase inhibitor 5-iodotubericidin, were reduc
87 w that 5-iodotubercidin (5-IT), an annotated adenosine kinase inhibitor previously reported to increa
91 enzoxy-Val-Ala-Asp-fluoromethyl ketone or an adenosine kinase inhibitor, but not in cultures with fet
92 romo-pyrazolo [3,4-d] pyrimidine, a specific adenosine kinase inhibitor-as well as continuous intra-a
93 platform, we identify a class of compounds [adenosine kinase inhibitors (ADK-Is)] that promote repli
94 As an alternative, we explored the use of adenosine kinase inhibitors (AKIs) as potential antiseiz
104 ibility that in our system the inhibition of adenosine kinase is related to an increase in intracellu
109 een shown that the activity of intracellular adenosine kinase preferentially controls the activation
113 nd ADO1, encoding an adenylate kinase and an adenosine kinase, respectively, negatively regulate PHO5
114 with endogenous adenosine kinase repression (adenosine kinase+/-) showed reduced infiltration of leuk
115 ied and incorporated into lead inhibitors of adenosine kinase that exhibited potent in vitro and in v
116 ot analysis demonstrated that the KD reduced adenosine kinase, the major adenosine-metabolizing enzym
117 hen FTOC were performed with an inhibitor of adenosine kinase, the major thymic deoxyadenosine phosph
118 lar to that proposed for both ribokinase and adenosine kinase, ThiK lacks an absolutely conserved Asp
121 th cDNA clones encoding catalytically active adenosine kinase were obtained from lymphocyte, placenta
122 ne deposition, homologous recombination, and adenosine kinase, which influences the methionine cycle.
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。